TickerFactsScreenerDevelopers

Larimar Therapeutics, Inc. (LRMR) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2011: $1.47M2012: $9.94M2013: $35.52M2014: $58.10M2015: $35.59M2016: $32.35M2017: $40.78M2018: $49.33M2019: $1.01M2020: $68.15M2021: $70.10M2022: $26.82M2023: $26.75M2024: $33.22M2025: $85.41M$85.41M
2011Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$85.41M+157.1%
2024$33.22M+24.2%
2023$26.75M-0.3%
2022$26.82M-61.7%
2021$70.10M+2.9%
2020$68.15M+6654.0%
2019$1.01M-98.0%
2018$49.33M+21.0%
2017$40.78M+26.0%
2016$32.35M-9.1%
2015$35.59M-38.7%
2014$58.10M+63.6%
2013$35.52M+257.5%
2012$9.94M+577.2%
2011$1.47M—